Pharma news, pharmaceutical news, Pharma Industry News, India Pharmaceutical Industry

Email us at buyorsell@ndtv.com
Call us at 011-26201171
BUDGET BUILD UP- INDIA'S TOP MINISTERS: AT 1 PM & 10:30 PM, SUN 3 PM
BUDGET BUILD UP- INDIA'S TOP MINISTERS: AT 1 PM & 10:30 PM, SUN 3 PM
BUDGET BUILD UP- INDIA'S TOP MINISTERS: AT 1 PM & 10:30 PM, SUN 3 PM
BUDGET BUILD UP- INDIA'S TOP MINISTERS: AT 1 PM & 10:30 PM, SUN 3 PM
IF FUEL AND BANK LIABILITIES ARE NOT PAID ON TIME, THE OPS COULD STOP
TO EMPLOYEES: NEED TO UNDERSTAND THAT CO IS IN DIRE FINANCIAL STRAITS
FOREIGN FUNDS NET BUY RS.210.82 CR IN EQUITIES ON JULY 3 (PROVISIONAL)
DOMESTIC FUNDS NET BUY RS.298.58 CR IN EQUITIES ON JULY 3 (PROVISIONAL)
RIL YET TO CHALLENGE BOMBAY HC ORDER WHICH WAS IN FAVOUR OF RNRL IN SC
RIL FILES A CAVEAT IN SC IN RESPONSE TO RNRL'S SPECIAL LEAVE PETITION
CLB ORDER IN THE MATTER OF MAHINDRA SATYAM EXPECTED ON MONDAY
RIL FILES A CAVEAT IN SC IN RESPONSE TO RNRL'S SPECIAL LEAVE PETITION
CLB ORDER ON THE MATTER EXPECTED ON MONDAY: SOURCES
OPEN TO 1-2 GOVT NOMINEES TO BE RETAINED FOR INVESTIGATION PURPOSE
MAHINDRA SATYAM BOARD HAS WRITTEN TO CLB TO RECALL GOVT NOMINATIONS
ASHOK LEYLAND SALES AT 3,971 UNITS VS 7,144 UNITS (YOY)
BHARTI GETS INTERPRETIVE ORDER FROM SEBI ON WAIVER OF OPEN OFFER
ORDER CONDITIONAL ON BHARTI GETTING NOD FOR SCHEME OF ARRANGEMENT BY HC
BHARTI WILL NEED SHAREHOLDER APPROVAL FOR SCHEME OF ARRANGEMENT
TATKAL BOOKING PERIOD REDUCED TO 2 DAYS FROM 5 NOW
TO FORM EXPERT COMMITTEE FOR OPTIC FIBRE CABLE NETWORK
PROVISION FOR NEW LINES AT RS.2921CR FROM RS,1100CR
RECEIVED INCREASED BUDGETARY SUPPORT BY RS.5000 CR IN FY'10
TO INTRODUCE 12 NEW NON STOP INTER-CITY TRAINS, DOUBLE DECKER AC COACHES
FREIGHT TRAFFIC TARGET AT 882 MT FOR FY'10 VS 833 MT IN FY'09
EXPECT RS.58500 CR REVS FROM FREIGHT, RS.23400 FROM PASSENGERS IN FY'10
FY'10 GROSS TRAFFIC RECEIPTS SEEN AT RS.8842 CR
RAILWAY FINANCE CORP TO BORROW RS.9000 CR IN FY'10

Updated: 27/06/09 | 02:35 PM IST

Pharma

Sun Pharma to come out with revised guidance‎

Sun Pharmaceuticals on Saturday said that it would come up with a revised guidance on its performance in the wake of action taken by the USFDA against Taraco Pharma, its US-based subsidiary.

Comments: Read (0) Post

Biocon chalks out growth plans

Even as the global slowdown has severely impacted the biotech sector, one of India’s largest pharma companies, Biocon, remains optimistic about the future growth. The company's promoter, Kiran Mazumdar Shaw is an exclusive interview to NDTV profit, said that opportunities are around the corner.

Comments: Read (0) Post

No intention of buying Ranbaxy: Pfizer

The Lipitor deal had further added to the speculation of Pfizer picking up a stake in Ranbaxy. But Pfizer on Wednesday told NDTV that it has no intention of picking up stake in Ranbaxy.

Comments: Read (0) Post

Special

India Inc cheers Rail Budget

Mamata Banerjee's grand expansion and modernisation plans could turn out to be a big bonanza for India Inc. From upgrading the stations to expanding rail network to running the 57 new trains, all are opportunities that the industry has been waiting for.